Connection
Daniel Pollyea to Tumor Suppressor Protein p53
This is a "connection" page, showing publications Daniel Pollyea has written about Tumor Suppressor Protein p53.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.162 |
|
|
|
-
Pollyea DA, Pratz KW, Wei AH, Pullarkat V, Jonas BA, Recher C, Babu S, Schuh AC, Dail M, Sun Y, Potluri J, Chyla B, DiNardo CD. Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and Azacitidine. Clin Cancer Res. 2022 12 15; 28(24):5272-5279.
Score: 0.162